Health
Sacubitril/Valsartan Treatment for HFpEF Shown to Reduce NT-proBNP Levels – AJMC.com Managed Markets Network
Wanting more data on the benefits of sacubitril/valsartan vs renin angiotensin system inhibitor background therapy, investigators…
Among several measures evaluated in a 24-week, randomized, double-blind, parallel group clinical trial comparing outcomes among patients with heart failure with preserved ejection fraction (HFpEF; left ventricular ejection fraction > 40%), sacubitril/valsartan…
Continue Reading
-
General10 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News13 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Business15 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth
-
Noosa News15 hours agoAustralia’s biggest sheep drive, and the young drover history forgot